Microbot Medical Expands Global IP Portfolio

Microbot Medical (NASDAQ:MBOT) announced that Intellectual Property India granted a patent covering the Company’s TipCAT technology platform.
As quoted in the press release:

“We continue to strengthen and expand our IP portfolio,” commented Harel Gadot, Chief Executive Officer, President, and Chairman. “As a pioneer in micro-robotic surgery, this will allow us to add value to our assets as it is expected to enhance our ability to access global markets and create additional competitive advantages and barriers to entry. India is a large and emerging market and we believe having a strong IP presence in this market further builds shareholder value.

Click here to read the full press release.

Source: globenewswire.com